Abstract
Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.
| Original language | English |
|---|---|
| Pages (from-to) | 37-39 |
| Number of pages | 3 |
| Journal | Nature Biotechnology |
| Volume | 34 |
| Issue number | 1 |
| Early online date | 8 Jan 2016 |
| DOIs | |
| Publication status | Published - Jan 2016 |